Ipsen S.A. - Etats financiers consolidés 2024
Pièce jointe
Corabotase is the first investigational molecule in a newly designated class of recombinant neuroinhibitors, RNITM, as recognized by the WHO and USAN Phase II data in glabellar (frown) lines to be...
Read MoreIpsen S.A. – Evolution of the composition of the Board of Directors PARIS, FRANCE, 13 MAY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that Mrs. Karen Witts has resigned from her position...
Read More